elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28252207-CD5767E7-8BE8-4FA4-BE64-8F9E43509429
Q28252207-CD5767E7-8BE8-4FA4-BE64-8F9E43509429
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28252207-CD5767E7-8BE8-4FA4-BE64-8F9E43509429
Risks and benefits of infliximab for the treatment of Crohn's disease
P356
Q28252207-CD5767E7-8BE8-4FA4-BE64-8F9E43509429
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28252207-CD5767E7-8BE8-4FA4-BE64-8F9E43509429
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
58660efd1d48394ce5568d0d2680f00c3696d4f3
P356
10.1016/J.CGH.2006.05.020
http://www.w3.org/2001/XMLSchema#string
P356
J.CGH.2006.05.020